Cancer News and Research

Latest Cancer News and Research

PecFent receives Positive Opinion from CHMP for treatment of BTCP

Archimedes Pharma, a leading specialty pharma company, today announced that its lead product, PecFent, has received a Positive Opinion from the Committee for Human Medicinal Products, of the European Medicines Agency. The CHMP is recommending PecFent, an innovative fentanyl nasal spray, be authorised for marketing in European Union countries for the treatment of breakthrough cancer pain - sudden, unpredictable episodes of intense pain that occur despite background pain medication.

25 Jun 2010

Research findings suggest possible diagnostic test for ALS

A team led by a Los Angeles Biomedical Research Institute researcher developed a novel approach to efficiently identify disease relevant genes in human complex neurological disorders and demonstrated the effectiveness of this method by applying it to Amyotrophic Lateral Sclerosis, or Lou Gehrig's Disease, according to a new study reported online in the journal, Human Molecular Genetics.

25 Jun 2010

HHS Secretary to speak about benefits of Affordable Care Act for women

Today, U.S. Secretary of Health and Human Services Secretary Kathleen Sebelius will speak to the National Partnership for Women and Families about how the Affordable Care Act will benefit women.

25 Jun 2010

Cyclosporine treatment develops higher de novo cancer risk in liver transplant patients: Researchers

Researchers at Erasmus MC University Medical Centre in The Netherlands found that cyclosporine treatment is a significant risk factor for the development of de novo cancer in liver transplant patients. Full details appear in the July issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

25 Jun 2010

PARP inhibitors may be effective in men with prostate cancer due to BRCA2 alteration: Researchers

The way prostate cancer develops in men who have an altered 'breast cancer gene' is the same route by which breast cancer develops in women with the same mutation, reveals a study published in PLoS Genetics today (Thursday).

25 Jun 2010

Study on effects of resveratrol on metabolism of microcebus murinus

Resveratrol is a natural substance that is widely studied, for its anti-ageing properties among other things. For the first time, work by a team in the "Mécanismes adaptatifs : des organismes aux communautés" Laboratory (CNRS/Muséum National d'Histoire Naturelle) has revealed that this compound reduces weight gain in lemurs. Such findings provide new information regarding the effects of resveratrol on energy metabolism and the control of body mass in primates. They may give a clearer understanding of the factors that govern obesity in humans. This study is published on 22 June 2010 in /BMC Physiology/.

25 Jun 2010

Specific virus can interact with mutation in host's genes to trigger diseases: Scientists

Scientists have shown that a specific virus can interact with a mutation in the host's genes to trigger disease. The observation may help explain why many people with disease risk genes do not actually develop disease.

25 Jun 2010

News roundup: Judge approves $712 million settlement for 9/11 emergency workers' health problems; Missouri ballot measure on health overhaul challenged

A judge approved a $712 million health settlement for thousands of emergency workers who responded after the Sept. 11 attack, in spite of objections from some who complained that the deal was unfair. Some workers who say they got sick working at the Ground Zero site argued Wednesday that the settlement shortchanged those suffering from certain types of diseases. One of the key factors in how much workers get paid under the settlement, approved by U.S. District Judge Alvin Hellerstein, depends on the type of disease the person contracted.

25 Jun 2010

Research on safety of endoscopic piecemeal mucosal resection in treatment of large sessile colorectal polyps

Endoscopic resection of large sessile colorectal polyps is increasingly used as an alternative to surgery, but remains challenging because of its technical difficulty, the high risk of complications such as bleeding or perforation, and the possibility of coexisting malignancy.

25 Jun 2010

Consumer-grade camera detects cancer cells in real time

Using an off-the-shelf digital camera, Rice University biomedical engineers and researchers from the University of Texas M.D. Anderson Cancer Center have created an inexpensive device that is powerful enough to let doctors easily distinguish cancerous cells from healthy cells simply by viewing the LCD monitor on the back of the camera.

From Evident Corporation - Life Sciences 25 Jun 2010

GI symptoms in peritoneal dialysis patients correlated with chronic renal failure

Gastrointestinal (GI ) symptoms are proven to be more common in patients undergoing peritoneal dialysis than in patients with chronic renal failure having hemodialysis. However, whether the onset of these GI symptoms is related to the chronic renal failure itself, its treatment, or alternatively, other factors, is still unknown

25 Jun 2010

Spiration to become a consolidated subsidiary of Olympus

Olympus Corporation is pleased to announce that an agreement was reached with Spiration, Inc. (Head Office: Redmond, Washington, U.S.A; President and CEO: Rick Shea) in which all shares of Spiration® will be acquired by Olympus Corporation of the Americas, a North American subsidiary of Olympus.

From Evident Corporation - Life Sciences 25 Jun 2010

Tanning protects skin from harmful sun rays

People who remain pale and never tan can blame their distant ancestors for choosing to live in the northern reaches of the globe and those who easily achieve a deep tan can thank their ancestors for living in the subtropical latitudes, according to Penn State anthropologists.

25 Jun 2010

Experts to meet in Miami to discuss new ways of avoiding errors in radiation therapy

A meeting in Miami this week will bring together some of the world's leading experts from inside and outside the clinic to discuss safety in radiation therapy -- a critical method for treating cancer.

25 Jun 2010

Sanofi-aventis' Phase I clinical trial with SAR650984 triggers $1M milestone payment to ImmunoGen

ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that sanofi-aventis has initiated a Phase I clinical trial with SAR650984, an investigational antibody that targets cancer cells expressing the CD38 protein antigen. This event triggers a $1 million milestone payment to ImmunoGen.

25 Jun 2010

Japanese researchers identity useful markers for early diagnosis of CMV gastritis

Cytomegalovirus (CMV) disease is a serious complication after allogeneic hematopoietic stem cell transplantation (allo-SCT), which is widely accepted as a curative therapy for advanced hematological malignancies including leukemia and malignant lymphoma.

25 Jun 2010

Mercy Hospital signs letter of intent to sell its facility to HCA

Today, Hospital Corporation of America, together with Mercy Hospital, announced they had entered into a letter of intent for the sale of the hospital to HCA. Mercy's board of directors voted to sell the facility to HCA, citing the company's presence in South Florida and consistent provision of quality care.

25 Jun 2010

FHCRC selects SciQuest to enhance its ERP system and improve on cost-efficiency

Fred Hutchinson Cancer Research Center, a world-renowned research and treatment institution in Seattle, has selected SciQuest, Inc., a leading provider of on-demand strategic procurement and supplier enablement solutions, to enhance its enterprise resource planning system and improve on cost-efficiency.

25 Jun 2010

Congressional hearing explores Medicare payment issues, including permanent 'doc fix'

A House Energy and Commerce Committee hearing Wednesday ostensibly about a recent Medicare Payment Advisory Commission report veered to discussion of the so-called "doc fix." The panel's chairman, Rep. Frank Pallone, D-N.J., called the ongoing efforts to delay the 21 percent cut in Medicare physician payments "the elephant in the room" and added that the "Democrats and Republicans in the House and Senate, as well as the physician community, need to work together to develop a permanent fix to this problem that has vexed all of us for far too long.

25 Jun 2010

Researchers develop new assay test for bladder cancer

Researchers from the Danish Cancer Society and the Herlev University Hospital of Copenhagen have developed a novel assay to test for multiple tumor markers in bladder cancer.

25 Jun 2010

Cancer News and Research

Latest Cancer News and Research

PecFent receives Positive Opinion from CHMP for treatment of BTCP

Research findings suggest possible diagnostic test for ALS

HHS Secretary to speak about benefits of Affordable Care Act for women

Cyclosporine treatment develops higher de novo cancer risk in liver transplant patients: Researchers

PARP inhibitors may be effective in men with prostate cancer due to BRCA2 alteration: Researchers

Study on effects of resveratrol on metabolism of microcebus murinus

Specific virus can interact with mutation in host's genes to trigger diseases: Scientists

News roundup: Judge approves $712 million settlement for 9/11 emergency workers' health problems; Missouri ballot measure on health overhaul challenged

Research on safety of endoscopic piecemeal mucosal resection in treatment of large sessile colorectal polyps

Consumer-grade camera detects cancer cells in real time

GI symptoms in peritoneal dialysis patients correlated with chronic renal failure

Spiration to become a consolidated subsidiary of Olympus

Tanning protects skin from harmful sun rays

Experts to meet in Miami to discuss new ways of avoiding errors in radiation therapy

Sanofi-aventis' Phase I clinical trial with SAR650984 triggers $1M milestone payment to ImmunoGen

Japanese researchers identity useful markers for early diagnosis of CMV gastritis

Mercy Hospital signs letter of intent to sell its facility to HCA

FHCRC selects SciQuest to enhance its ERP system and improve on cost-efficiency

Congressional hearing explores Medicare payment issues, including permanent 'doc fix'

Researchers develop new assay test for bladder cancer

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in